Short answer
Aquestive Therapeutics, Inc. (AQST) filed an 8-K current report with the SEC on February 26, 2026 reporting Item 7.01 (Regulation FD Disclosure). Aquestive Therapeutics conducting institutional investor/analyst roadshow meetings.
Aquestive Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Aquestive Therapeutics conducting institutional investor/analyst roadshow meetings
- Full presentation content in Exhibit 99.1: key product pipeline and financial details located there
- Company reserves right to amend or update disclosed information via future filings
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Aquestive Therapeutics, Inc. 8-K filings
Get the next AQST 8-K as it lands
Follow AQST for push alerts, or ask the research agent what this filing means.